2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC Clinical Study in Advanced Non-small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, June 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Telix Manufacturing Solutions (TMS) Established in Yokohama, Japan
MELBOURNE, Australia and KYOTO, Japan, June 4, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that it has established Telix Manufacturing Solutions (TMS) in Yokohama, Japan. Telix's...
The GrowHub Announces Expansion of Research & Development Team to Accelerate AI Development and Capabilities
SINGAPORE, June 4, 2025 /PRNewswire/ -- THE GROWHUB LIMITED ("The GrowHub" or the "Company"), a Singapore-based company leveraging blockchain technology to enhance product traceability and authenticity for products along the entire supply chain,...
3i Announces Launch of the G10+: World's First Robot Vacuum with Debris Compression & Extendable Mop
Enjoy 60 days of hands-free, bagless dust collection in a quieter, more compact, and eco-conscious robot vacuum HONG KONG, June 3, 2025 /PRNewswire/ -- 3i, a pioneering smart home brand, is thrilled to announce the launch of the 3i G10+, the World's...
HUDA BEAUTY RECLAIMS FULL OWNERSHIP AS AN INDEPENDENT BEAUTY BRAND
DUBAI, UAE, June 3, 2025 /PRNewswire/ -- Huda Beauty, the globally renowned beauty brand, proudly announces that it has reclaimed full ownership as an independent brand following the conclusion of its eight-year partnership with TSG Consumer...
Energys Group Secures New Energy Efficient Lighting Contracts Upon Successful Completion of Initial Phase
BILLINGSHURST, UK, June 3, 2025 /PRNewswire/ -- Energys Group Limited (NASDAQ: ENGS) ("Energys Group" or the "Company", together with its subsidiaries, the "Group"), a vertically integrated energy efficiency and decarbonisation solutions provider...
Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)
EBC-129 is an antibody-drug conjugate (ADC) that selectively targets a novel, tumour-specific N-glycosylated epitope found on both CEACAM5 and CEACAM6. The expansion cohort for pancreatic ductal adenocarcinoma (PDAC) in the ongoing Phase 1 trial has...
Self Storage Awards Asia Gala Dinner announces winners at Self Storage Expo Asia 2025
HONG KONG, June 3, 2025 /PRNewswire/ -- The Self Storage Association Asia announces the Self Storage Association Awards Asia 2025 winners in Tokyo. The Awards recognise Asia-wide and local excellence in self storage in customer service, the use of...
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...